GRI Bio, Inc.

Research - San Diego, California, United States

GRI Bio, Inc. Details

GRI is a development stage biotech company fundamentally changing the way inflammatory disease is treated. GRI's Natural Killer T (NKT) cell-based therapies are being developed for liver disease and acute liver failure. NKT cells share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type 1 NKT cells play a critical role in initiating and propagating the inflammatory response and the hepatic injury that is observed in liver disease. GRI's lead program, GRI-0621, is an inhibitor of type I NKT cells and is being developed as a novel oral therapeutic for acute liver failure.

GRI Bio, Inc. logo, GRI Bio, Inc. contact details
Employees: 5
HQ: (619) 400-1171
Location: San Diego, California, United States
Revenue: 4.7M
GRI Bio, Inc. Technologies
Email Providers

Gmail

Load Balancers

Apache

Fonts

Google Font API

Other

Mobile Friendly

CSS and JavaScript Libraries

Bootstrap Framework

View All Technologies Used At GRI Bio, Inc.

Contacting GRI Bio, Inc.: Connect with Executives and Employees

Get in Touch with GRI Bio, Inc. Executives and Employees

Connecting with GRI Bio, Inc.'s Executives and Workforce

Accessing Contact Information for GRI Bio, Inc. Executives

Connecting with GRI Bio, Inc.: Reach Out to Their Team

Discover How to Contact GRI Bio, Inc. Executives and Staff

Looking to connect with GRI Bio, Inc. executives or employees?

Seeking to Get in Touch with GRI Bio, Inc. Executives or Staff?

Want to Reach Out to GRI Bio, Inc. Executives or Team Members?

In Search of Contact Details for GRI Bio, Inc. Professionals?

Connecting with GRI Bio, Inc.: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z